Ontology highlight
ABSTRACT: Background and purpose
Glioblastoma (GBM) patients have a dismal prognosis. Tumours typically recur within months of surgical resection and post-operative chemoradiation. Multiparametric magnetic resonance imaging (mpMRI) biomarkers promise to improve GBM outcomes by identifying likely regions of infiltrative tumour in tumour probability (TP) maps. These regions could be treated with escalated dose via dose-painting radiotherapy to achieve higher rates of tumour control. Crucial to the technical validation of dose-painting using imaging biomarkers is the repeatability of the derived dose prescriptions. Here, we quantify repeatability of dose-painting prescriptions derived from mpMRI.Materials and methods
TP maps were calculated with a clinically validated model that linearl
SUBMITTER: Brighi C
PROVIDER: S-EPMC9207284 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature